Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (Nature, (2020), 586, 7830, (594-599), 10.1038/s41586-020-2814-7)

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, Isabel Vogler, Lena M. Kranz, Mathias Vormehr, Alina Baum, Kristen Pascal, Jasmin Quandt, Daniel Maurus, Sebastian Brachtendorf, Verena Lörks, Julian Sikorski, Rolf Hilker, Dirk Becker, Ann Kathrin Eller, Jan Grützner, Carsten Boesler, Corinna Rosenbaum, Marie Cristine KühnleUlrich Luxemburger, Alexandra Kemmer-Brück, David Langer, Martin Bexon, Stefanie Bolte, Katalin Karikó, Tania Palanche, Boris Fischer, Armin Schultz, Pei Yong Shi, Camila Fontes-Garfias, John L. Perez, Kena A. Swanson, Jakob Loschko, Ingrid L. Scully, Mark Cutler, Warren Kalina, Christos A. Kyratsous, David Cooper, Philip R. Dormitzer, Kathrin U. Jansen, Özlem Türeci

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the print version of this Article, some of the symbols were corrupted in Figs. 1, 2 and 4. The HTML and PDF versions of the Article were correct, and so the original Article has not been corrected online.

Original languageEnglish (US)
Pages (from-to)E17
JournalNature
Volume590
Issue number7844
DOIs
StatePublished - Feb 4 2021

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses (Nature, (2020), 586, 7830, (594-599), 10.1038/s41586-020-2814-7)'. Together they form a unique fingerprint.

Cite this